EUR 9.1
(0.0%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | - EUR | -100.0% |
2022 | 12.9 Million EUR | 2680.0% |
2021 | -500 Thousand EUR | -100.57% |
2020 | 87.7 Million EUR | 1786.54% |
2019 | -5.2 Million EUR | 88.77% |
2018 | -46.3 Million EUR | 53.14% |
2017 | -98.8 Million EUR | -18.32% |
2016 | -83.5 Million EUR | -85.97% |
2015 | -44.9 Million EUR | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q1 | - EUR | 100.0% |
2024 Q2 | - EUR | 0.0% |
2023 Q2 | 5.5 Million EUR | 0.0% |
2023 Q1 | 5.5 Million EUR | -90.6% |
2023 Q4 | -5.5 Million EUR | 0.0% |
2023 Q3 | -5.5 Million EUR | -200.0% |
2023 FY | - EUR | -100.0% |
2022 Q1 | 6 Million EUR | 0.0% |
2022 Q2 | 6 Million EUR | 0.0% |
2022 Q3 | 58.5 Million EUR | 875.0% |
2022 Q4 | 58.5 Million EUR | 0.0% |
2022 FY | 12.9 Million EUR | 2680.0% |
2021 Q2 | 1 Million EUR | 0.0% |
2021 FY | -500 Thousand EUR | -100.57% |
2021 Q1 | 1 Million EUR | -99.79% |
2020 Q1 | -15 Million EUR | 67.74% |
2020 FY | 87.7 Million EUR | 1786.54% |
2020 Q4 | 469.5 Million EUR | 4.68% |
2020 Q2 | -15 Million EUR | 0.0% |
2020 Q3 | 448.5 Million EUR | 3090.0% |
2019 Q1 | 19.5 Million EUR | 116.39% |
2019 Q4 | -46.5 Million EUR | 0.0% |
2019 Q2 | 19.5 Million EUR | 0.0% |
2019 FY | -5.2 Million EUR | 88.77% |
2019 Q3 | -46.5 Million EUR | -338.46% |
2018 Q2 | -112.5 Million EUR | 0.0% |
2018 Q3 | -119 Million EUR | -5.78% |
2018 Q4 | -119 Million EUR | 0.0% |
2018 FY | -46.3 Million EUR | 53.14% |
2018 Q1 | -112.5 Million EUR | 68.75% |
2017 FY | -98.8 Million EUR | -18.32% |
2017 Q4 | -360 Million EUR | 0.0% |
2017 Q3 | -360 Million EUR | -168.66% |
2017 Q2 | -134 Million EUR | 0.0% |
2017 Q1 | -134 Million EUR | 43.7% |
2016 Q1 | -179.5 Million EUR | -729.1% |
2016 FY | -83.5 Million EUR | -85.97% |
2016 Q4 | -238 Million EUR | 0.0% |
2016 Q3 | -238 Million EUR | -32.59% |
2016 Q2 | -179.5 Million EUR | 0.0% |
2015 FY | -44.9 Million EUR | 0.0% |
2015 Q2 | -12.4 Million EUR | 0.0% |
2015 Q1 | -12.4 Million EUR | 0.0% |
2015 Q4 | -21.65 Million EUR | -74.6% |
2015 Q3 | -12.4 Million EUR | 0.0% |
2014 Q4 | -12.4 Million EUR | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
AB Science S.A. | -10.04 Million EUR | 100.0% |
Boiron SA | 35.82 Million EUR | 100.0% |
Ipsen S.A. | 644.4 Million EUR | 100.0% |
Vetoquinol SA | 55.56 Million EUR | 100.0% |